Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells
- PMID: 23754252
- DOI: 10.3892/ijo.2013.1978
Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells
Abstract
Fatty acid synthase is highly expressed in many types of human cancers. Cerulenin, a natural inhibitor of fatty acid synthase, induced apoptosis in the human colon cancer cell lines HCT116 and RKO. Oxaliplatin also induced cell death in these cell lines. Cerulenin treatment was associated with reduced levels of phosphorylated Akt, activation of p38 and induced caspase-3 cleavage and finally caused apoptosis. Oxaliplatin induced activation of the p53-p21 pathway and p38. In combination with cerulenin and oxaliplatin, activation of the p53-p21 pathway and p38 occurred in a smaller concentration and finally induced caspase-3 cleavage in a smaller concentration of cerulenin and oxaliplatin. In xenotransplanted SCID mice, the cerulenin + oxaliplatin group significantly inhibited tumor progression compared to the control, cerulenin and oxaliplatin groups. Based on these studies, inhibiting fatty acid synthase would be an effective strategy to treat unresectable colorectal cancer tumors in combination with oxaliplatin. Fatty acid synthase inhibitor would be one of the best counterparts of oxaliplatin, which reduces the dose and side-effects of oxaliplatin and would make it possible to endure the chemotherapy over a longer period.
Similar articles
-
Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.Biochem Pharmacol. 2005 Sep 1;70(5):658-67. doi: 10.1016/j.bcp.2005.05.028. Biochem Pharmacol. 2005. PMID: 16004971
-
Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells.Biomed Pharmacother. 2007 Oct;61(9):578-87. doi: 10.1016/j.biopha.2007.08.020. Epub 2007 Sep 14. Biomed Pharmacother. 2007. PMID: 17904792
-
Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice.Cancer Sci. 2010 Aug;101(8):1861-5. doi: 10.1111/j.1349-7006.2010.01596.x. Epub 2010 Apr 21. Cancer Sci. 2010. PMID: 20491775 Free PMC article.
-
Anti-cancer drugs targeting fatty acid synthase (FAS).Recent Pat Anticancer Drug Discov. 2012 May 1;7(2):185-97. doi: 10.2174/157489212799972891. Recent Pat Anticancer Drug Discov. 2012. PMID: 22338595 Review.
-
Natural fatty acid synthase inhibitors as potent therapeutic agents for cancers: A review.Pharm Biol. 2016 Sep;54(9):1919-25. doi: 10.3109/13880209.2015.1113995. Epub 2016 Feb 10. Pharm Biol. 2016. PMID: 26864638 Review.
Cited by
-
p53 and metabolism: from mechanism to therapeutics.Oncotarget. 2018 May 4;9(34):23780-23823. doi: 10.18632/oncotarget.25267. eCollection 2018 May 4. Oncotarget. 2018. PMID: 29805774 Free PMC article. Review.
-
Metabolic Strategies for Inhibiting Cancer Development.Adv Nutr. 2021 Jul 30;12(4):1461-1480. doi: 10.1093/advances/nmaa174. Adv Nutr. 2021. PMID: 33530098 Free PMC article. Review.
-
Frondoside A Enhances the Anti-Cancer Effects of Oxaliplatin and 5-Fluorouracil on Colon Cancer Cells.Nutrients. 2018 May 1;10(5):560. doi: 10.3390/nu10050560. Nutrients. 2018. PMID: 29724012 Free PMC article.
-
Targeting cytosolic phospholipase A2 α in colorectal cancer cells inhibits constitutively activated protein kinase B (AKT) and cell proliferation.Oncotarget. 2014 Dec 15;5(23):12304-16. doi: 10.18632/oncotarget.2639. Oncotarget. 2014. PMID: 25365190 Free PMC article.
-
Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer.Mol Ther. 2016 Dec;24(12):2064-2077. doi: 10.1038/mt.2016.180. Epub 2016 Sep 16. Mol Ther. 2016. PMID: 27633443 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
